Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» FPA008
FPA008
Five Prime Therapeutics Receives FDA Orphan Drug Designation for FPA008 in Pigmented Villonodular Synovitis (PVNS)
Yahoo
Wed, 01/13/16 - 09:57 am
Five Prime
FDA
orphan drugs
FPA008
PVNS
Bristol-Myers, Five Prime enter licensing deal of up to $1.74 bln
Yahoo/Reuters
Thu, 10/15/15 - 08:44 am
Bristol-Myers Squibb
Five Prime
FPA008
cancer immunotherapy
Five Prime gets $30M upfront from Bristol-Myers and will study combination cancer treatment
Yahoo/AP
Mon, 11/24/14 - 06:03 pm
Five Prime
Bristol-Myers Squibb
Opdivo
FPA008
melanoma